LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
奧洛茲美醫療
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
美股市場個股詳情
PTCT PTC Therapeutics
- 45.230
- -0.610-1.33%
收盤價 12/27 16:00 (美東)
- 45.230
- 0.0000.00%
盤後 16:04 (美東)
34.88億總市值-7.61市盈率TTM
46.110最高價44.700最低價34.66萬股成交量45.340今開45.840昨收1565.92萬成交額0.57%換手率虧損市盈率(靜)7712.51萬總股本54.16052周最高-3.31市淨率27.46億流通值23.58052周最低--股息TTM6071.10萬流通股78.720歷史最高--股息率TTM3.08%振幅4.030歷史最低45.182平均價1股每手
關於PTC Therapeutics公司
PTC Therapeutics Inc 是一家生物製藥公司，專注於口服小分子療法的發現、開發和商業化。 其目標領域是在轉錄過程中從 DNA 複製 RNA 信使時發生在細胞中的事件的 RNA 生物學轉錄後控制過程。 該公司所發現的產品涉及多個治療領域，包括罕見疾病，例如杜氏肌營養不良症和腫瘤學中的無義突變。
公司介紹
公司代碼PTCT
公司名稱PTC Therapeutics
上市日期2013/06/20
發行價格15.00
成立日期1998
CEODr. Matthew B. Klein, F.A.C.S.,M.D.,M.S.
所屬市場納斯達克
員工數量995
年結日12-31
公司地址500 Warren Corporate Center Drive
城市Warren
省份新澤西
國家美國
郵編07059
電話1-908-222-7000
董事高管
- 姓名
- 職務
- 年薪
- Dr. Matthew B. Klein, F.A.C.S.,M.D.,M.S.
- Director, President and Chief Executive Officer
- 893.70萬
- Mark E. Boulding
- Executive Vice President and Chief Legal Officer
- 219.08萬
- Eric Pauwels
- Chief Business Officer
- 241.26萬
- Neil Alead
- Chief Technical Operations Officer
- --
- Christine Utter
- Senior Vice President, Chief Accounting Officer and Head, People Services
- --
- Pierre Gravier
- Chief Financial Officer
- 273.45萬
- Dr. Lee Golden, M.D.
- Executive Vice President and Chief Medical Officer
- 239.50萬
- Michael Schmertzler
- Chairman of the Board
- 81.70萬
- Dr. Allan Jacobson, PhD
- Independent Director
- 51.20萬
- Alethia Young
- Independent Director
- 42.90萬
- William F. Bell, Jr
- Independent Director
- 68.84萬
- David P. Southwell
- Independent Director
- 43.90萬
- Stephanie S. Okey, M.S.
- Independent Director
- 42.20萬
- Emma Reeve
- Independent Director
- 44.20萬
- Dr. Jerome Bernard Zeldis, M.D.,PhD
- Independent Director
- 42.20萬
- Dr. Glenn D. Steele, M.D., Ph.D.
- Independent Director
- 42.70萬
- Mary Smith
- Independent Director
- 43.90萬